Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)

NCT05612802 is registered in ClinicalTrials.gov with Baskent University as lead sponsor.

NCT NCT05612802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05612802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)
Lead sponsor
Baskent University
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2023
Completion date
May 30, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury (nontraumatic), pneumoperitoneum